Azole resistant Candida glabrata vulvovaginitis treated with boric acid.
Savini
Vincenzo
V
Catavitello
Chiara
C
Bianco
Azaira
A
Balbinot
Andrea
A
D'Antonio
Francesco
F
D'Antonio
Domenico
D
D000328:Adult; D000935:Antifungal Agents / Q000494:pharmacology / Q000627:therapeutic use; D001888:Boric Acids / Q000494:pharmacology / Q000627:therapeutic use*; D041221:Candida glabrata / Q000187:drug effects / Q000502:physiology*; D002177:Candidiasis / Q000188:drug therapy* / Q000382:microbiology; D025141:Drug Resistance, Fungal / Q000502:physiology*; D005260:Female; D015725:Fluconazole / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D007306:Insecticides / Q000494:pharmacology / Q000627:therapeutic use; D017964:Itraconazole / Q000494:pharmacology / Q000627:therapeutic use*; D016896:Treatment Outcome; D014848:Vulvovaginitis / Q000188:drug therapy* / Q000382:microbiology
D000935:Antifungal Agents; D001888:Boric Acids; D007306:Insecticides; D017964:Itraconazole; D015725:Fluconazole; C032688:boric acid